Shusuke Yoshikawa

1.6k total citations
63 papers, 768 citations indexed

About

Shusuke Yoshikawa is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, Shusuke Yoshikawa has authored 63 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 20 papers in Dermatology and 19 papers in Molecular Biology. Recurrent topics in Shusuke Yoshikawa's work include Cutaneous Melanoma Detection and Management (20 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Nonmelanoma Skin Cancer Studies (16 papers). Shusuke Yoshikawa is often cited by papers focused on Cutaneous Melanoma Detection and Management (20 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Nonmelanoma Skin Cancer Studies (16 papers). Shusuke Yoshikawa collaborates with scholars based in Japan, United States and United Kingdom. Shusuke Yoshikawa's co-authors include Yoshio Kiyohara, Naoya Yamazaki, Tetsuya Tsuchida, Yasushi Ishihara, Toshiaki Saida, Kunihiko Tamaki, Yasuhiro Kawabata, Shinji Oguchi, Sumio Murase and Atsushi Miyazaki and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Optics Express.

In The Last Decade

Shusuke Yoshikawa

54 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shusuke Yoshikawa Japan 15 555 238 218 170 155 63 768
João Pedreira Duprat Neto Brazil 16 713 1.3× 379 1.6× 126 0.6× 226 1.3× 112 0.7× 78 1.0k
Lutz Kretschmer Germany 19 765 1.4× 286 1.2× 157 0.7× 338 2.0× 174 1.1× 63 1.0k
Tatsuya Takenouchi Japan 17 767 1.4× 369 1.6× 248 1.1× 326 1.9× 355 2.3× 70 1.1k
Adi Nosrati United States 13 671 1.2× 210 0.9× 354 1.6× 124 0.7× 107 0.7× 22 911
Judit Oláh Hungary 15 365 0.7× 169 0.7× 160 0.7× 117 0.7× 128 0.8× 54 718
Marco Palla Italy 14 576 1.0× 294 1.2× 293 1.3× 136 0.8× 59 0.4× 42 911
Sebastián Podlipnik Spain 13 428 0.8× 186 0.8× 77 0.4× 139 0.8× 140 0.9× 84 627
Sandrine Mansard France 12 499 0.9× 180 0.8× 130 0.6× 346 2.0× 231 1.5× 37 799
Adam Mor United States 16 423 0.8× 263 1.1× 421 1.9× 89 0.5× 45 0.3× 45 929
Robert V. Rawson Australia 14 461 0.8× 200 0.8× 155 0.7× 71 0.4× 49 0.3× 49 599

Countries citing papers authored by Shusuke Yoshikawa

Since Specialization
Citations

This map shows the geographic impact of Shusuke Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shusuke Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shusuke Yoshikawa more than expected).

Fields of papers citing papers by Shusuke Yoshikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shusuke Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shusuke Yoshikawa. The network helps show where Shusuke Yoshikawa may publish in the future.

Co-authorship network of co-authors of Shusuke Yoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shusuke Yoshikawa. A scholar is included among the top collaborators of Shusuke Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shusuke Yoshikawa. Shusuke Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Goto, Keisuke, et al.. (2023). Carcinoid-Like Cell Arrangements in Basal Cell Carcinoma: A Study of 11 Cases. International Journal of Surgical Pathology. 31(8). 1466–1472.
5.
Tsutsumida, Arata, Satoshi Fukushima, Kenji Yokota, et al.. (2019). Japanese real‐world study of sequential nivolumab and ipilimumab treament in melanoma. The Journal of Dermatology. 46(11). 947–955. 13 indexed citations
6.
Ueno, Hideki, Shunsuke Kondo, Shusuke Yoshikawa, et al.. (2018). A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors. Investigational New Drugs. 36(4). 647–656. 20 indexed citations
7.
Namikawa, Kenjiro, Yoshio Kiyohara, Tatsuya Takenouchi, et al.. (2018). Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study. European Journal of Cancer. 105. 114–126. 50 indexed citations
8.
Kiyohara, Yoshio, Shusuke Yoshikawa, Masaki Otsuka, et al.. (2017). Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi‐OMICS analysis in Project HOPE. The Journal of Dermatology. 44(10). 1156–1159. 1 indexed citations
9.
Ogata, Dai, Hisashi Uhara, Arata Tsutsumida, et al.. (2017). Nail apparatus melanoma in a Japanese population: a comparative study of surgical procedures and prognoses in a large series of 151 cases. European Journal of Dermatology. 27(6). 620–626. 16 indexed citations
10.
Yamazaki, Naoya, Yoshio Kiyohara, Hisashi Uhara, et al.. (2015). Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma. Cancer Chemotherapy and Pharmacology. 76(5). 997–1004. 56 indexed citations
11.
Nakashima, Kazuhisa, Tateaki Naito, Shota Omori, et al.. (2015). Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma. Journal of Thoracic Oncology. 11(3). 432–433. 28 indexed citations
12.
Imai, Hisao, Yoshio Kiyohara, Shusuke Yoshikawa, et al.. (2014). Primary malignant melanoma of the trachea: A case report. Oncology Letters. 9(2). 657–660. 5 indexed citations
13.
Fuji, Hiroshi, Shusuke Yoshikawa, Masako Kasami, et al.. (2014). High-dose proton beam therapy for sinonasal mucosal malignant melanoma. Radiation Oncology. 9(1). 162–162. 41 indexed citations
14.
Ogata, Dai, Yoshio Kiyohara, Shusuke Yoshikawa, & Masako Kasami. (2013). Treatment strategy for cutaneous apocrine carcinoma. International Journal of Clinical Oncology. 19(4). 712–715. 19 indexed citations
15.
Ogata, Dai, Takayoshi Uematsu, Shusuke Yoshikawa, & Yoshio Kiyohara. (2013). Accuracy of real-time ultrasound elastography in the differential diagnosis of lymph nodes in cutaneous malignant melanoma (CMM): a pilot study. International Journal of Clinical Oncology. 19(4). 716–721. 16 indexed citations
16.
Oshita, Chie, Akiko Kume, Haruo Miyata, et al.. (2012). Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial. Oncology Reports. 28(4). 1131–1138. 83 indexed citations
17.
Iwatate, Mineo, Hiroyuki Matsubayashi, Keiko Sasaki, et al.. (2010). Functional Pancreatic Acinar Cell Carcinoma Extending into the Main Pancreatic Duct and Splenic Vein. Journal of Gastrointestinal Cancer. 43(2). 373–378. 10 indexed citations
18.
Iizuka, Akira, Masaru Komiyama, Sachiko Tai, et al.. (2010). Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients. Immunology Letters. 135(1-2). 64–73. 7 indexed citations
19.
Ogata, Dai, et al.. (2009). Two Cases of Anorectal Malignant Melanoma. The Nishinihon Journal of Dermatology. 71(3). 269–274. 1 indexed citations
20.
Saida, Toshiaki, Atsushi Miyazaki, Shinji Oguchi, et al.. (2004). Significance of Dermoscopic Patterns in Detecting Malignant Melanoma on Acral Volar Skin. Archives of Dermatology. 140(10). 1233–8. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026